MedPath

Clinical Effect of Massage Chair on Older Adults

Not Applicable
Completed
Conditions
Older Adults
Interventions
Device: massage chair
Registration Number
NCT03732729
Lead Sponsor
Eunju Lee
Brief Summary

The use of massage chairs is becoming more popular in many countries. According to the previous reports, some manual massages have positive effects on the mood, pain, fatigue, and sleep quality. However, the clinical benefits of the massage chair have not been fully understood. In this trial, it is aimed to evaluate the clinical effectiveness of the 6-month regular use of massage chair twice a day. It is hypothesized that long-term regular use of massage chair has positive effects on the hormonal level related to the stress, inflammation, and aging, as well as physical, psychologic, and muscle quality.

Detailed Description

A total of enrolled 80 patients after randomization(1:1) in intervention(Massage chair)group and Control groups, will be provided

* Massage chair group

* lifestyle modification education + using massage chair twice per day during 24weeks

* control group: only lifestyle modification education

1. Screening visit

* collection demographic data, BMD, vital sign, Medication history

2. Visit 1 (0-week)

1. Vital sign

2. Charlson comorbidity index

3. Laboratory test

* WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol, serotonin, DHEA-s, IGF-1, NK cell, Telomere length

4. Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L

5. Physical\& muscular assessment

* SPPB, Grip strength, Muscle tone, Bioimpedance analysis

3. Visit 2-6 (4,8,12,16 weeks) via Phone contact: assess compliance and adverse events

4. visit 7 (24weeks)

1. Vital sign

2. Laboratory test

* WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol, serotonin, DHEA-s, IGF-1, NK cell, Telomere length

3. Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L

4. Physical\& muscular assessment

* SPPB, Grip strength, Muscle tone, Bioimpedance analysis

5. Compliance

6. Adverse events

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Community-dwelling healthy adults between 50-75 years old
Exclusion Criteria
  1. Unable to sign his/her own informed consent
  2. Any disability or damages in 4 extremity.
  3. Who have exercised regularly more than twice a week during the last 24 weeks
  4. Who have received regular massage during the last 24 weeks
  5. Confirmed osteoporosis of T score <-2.5 from BMD or history of compression fracture
  6. Cortisol-metabolism disorders or other diseases that can affect steroid secretion
  7. Who have taken any medication related with steroid secretion or metabolism within 2 weeks
  8. Expected life expectancy less than 12 months (Symptomatic heart failure, end-stage renal failure)
  9. Spouse is already enrolled in this research

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Massage chairmassage chairlifestyle modification education(once)+ Using massage chair
Primary Outcome Measures
NameTimeMethod
Serum cortisol levelChange from baseline serum cortisol level at 24weeks

Investigate serum cortisol level of baseline \& 24weeks between 2 groups.

Secondary Outcome Measures
NameTimeMethod
Cortisol/DHEA-s ratioChange from Baseline cortisol/DHEA-s ratio level at 24weeks

Investigate serum Cortisol/DHEA-s ratio level of baseline \& 24weeks between 2 groups.

Serum Serotonin levelChange from Baseline serum serotonin level at 24weeks

Investigate serum serotonin level of baseline \& 24weeks between 2 groups.

hsCRPChange from Baseline hs CRP level at 24weeks

Investigate serum hsCRP level of baseline \& 24weeks between 2 groups.

Korean version Short form Geriatric Depression Scale(SGDS-K) scoreSGDS-K summed total score is changed lower at 24weeks from baseline

15 item measure to assess the depression

Serum IGF-1 levelChange from Baseline Serum IGF-1 level level at 24weeks

Investigate serum IGF-1 level of baseline \& 24weeks between 2 groups.

Telomere lengthChange from Baseline Telomere length level at 24weeks

Investigate Telomere length of baseline \& 24weeks between 2 groups

The 5-level EQ-5D version(EQ-5D-5L) scoreEQ-5D-5L summed total score is changed higher at 24weeks from baseline

6 item measure to assess the quality of life

NK cell activityChange from Baseline NK cell activity level at 24weeks

Investigate serum NK cell activity of baseline \& 24weeks between 2 groups.

Muscle tone scoreIndividual site Muscle tone score is changed higher at 24weeks from baseline

6 item measure to assess Muscle tone of both trapezoid\& forearm \& thigh

ESRChange from Baseline ESR level at 24weeks

Investigate serum ESR level of baseline \& 24weeks between 2 groups.

Korean version -Brief Encounter Psychosocial Instrument(BEPSI-K) scoreBEPSI-K summed total score is changed lower at 24weeks from baseline

5 item measure to assess the Stress

Trial Locations

Locations (1)

AsanMC

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath